Stop Gambling in the Stock Market. Be an intelligent and confident investor.
See what the professionals see with financial analytics, charts and valuation models.
Fundamental Analysis and Stock Valuation Simplified. Learn more.

Glenmark Pharmaceuticals Ltd. | GLENMARK | NSE - Pharmaceuticals


Performance Trend  |  Valuation  |  Growth  |  Insiders  |  Summary
Balance Sheet  | Income Statement  |  Cash Flow  |  Quarterly
INR in Million except EPS. Fiscal year ends in March. Figures are consolidated and restated.

Upgrade Membership to see 10 year financial statements.

  
2015
2016
2017
2018
2019
Revenue
Revenue
66,29876,49691,85791,03198,655
Cost of revenue
Cost of revenue
-19,344-23,026-26,143-30,386-33,623
Gross Profit
Gross Profit
46,953
53,470
65,714
60,645
65,031
Sales, general & ad...
Sales, general and administrative
-36,728-39,098-45,347-44,491-49,173
Depreciation
Depreciation and amortization
-2,600-2,343-2,644-3,019-3,259
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
7,625
12,029
17,723
13,135
12,599
 
      
Interest expense
Interest expense
-1,902-1,789-2,373-2,856-3,346
Other income/exp...
Other income(expense)
219200-4369143,753
Profit before tax
Profit before tax
5,943
10,440
14,914
11,193
13,006
Income tax & other ta...
Income tax and other taxes
1,1903,0093,8273,1553,756
Net income from c...
Net income from continuing operations
4,7527,43011,0888,0399,250
Extraordinary & disc...
Extraordinary items & Discontinued Ops
00000
Share of associates
Share of associates
00000
Minority Interest
Minority Interest
00000
Net Income
Net income
4,752
7,430
11,088
8,039
9,250
 
      
NI - Preferred Di...
Net Income after Preferred Dividend and Others
4,7527,43011,0888,0399,250
Basic shares
Basic shares
271281282282282
Diluted Shares
Diluted Shares
271281282282282
EPS Basic
EPS Basic in Rupees
17.5226.4739.2928.4932.78
EPS Diluted
EPS Diluted in Rupees
17.51
26.46
39.28
28.49
32.78